Login
$MEDS
$2.06 -$0.13 (5.94%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net
Nonrelated Party
Related Party
Total accounts receivable, net
Inventories, net
Due from related party
Related Party
Total due from related party
Subscription receivable
Deferred offering costs
Prepaid and other current assets
Total current assets
Property, plant and equipment, net
Intangible assets under development
Capitalized software
Operating lease, right-of-use assets
Goodwill
Other intangible assets, net
Note receivable
Investments in unconsolidated entity
Other assets
Deposits
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable
Nonrelated Party
Related Party
Accrued expenses and other liabilities
Other short-term advances
Due to related parties
Nonrelated Party
Seller
Related Party
Total due to related parties
Convertible notes payable, net of debt discount
Current portion of debt obligations, net of debt discount
Operating lease liabilities- current portion
Total current liabilities
Notes payable
Nonrelated Party
Related Party
Loan payable
Operating lease liabilities
Total liabilities
Stockholders’ equity (deficit):
Common stock, $0.0001 par value, 500,000,000 shares authorized, 2,847,198 and 2,045,792 shares issued and 2,836,484 and 2,026,150 shares outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support